Act Advisors, Llc. Rani Therapeutics Holdings, Inc. Transaction History
Act Advisors, Llc.
- $241 Million
- Q3 2025
A detailed history of Act Advisors, Llc. transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Act Advisors, Llc. holds 14,806 shares of RANI stock, worth $42,345. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,806Holding current value
$42,345% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RANI
# of Institutions
45Shares Held
6.34MCall Options Held
29.4KPut Options Held
0-
Armistice Capital, LLC New York, NY3.15MShares$9.01 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA800KShares$2.29 Million0.0% of portfolio
-
Nan Fung Group Holdings LTD Central, K3494KShares$1.41 Million0.48% of portfolio
-
United Services Automobile Association San Antonio, TX303KShares$865,8440.02% of portfolio
-
Geode Capital Management, LLC Boston, MA191KShares$544,9930.0% of portfolio
About Rani Therapeutics Holdings, Inc.
- Ticker RANI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 24,492,000
- Market Cap $70M
- Description
- Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...